Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report

BACKGROUND: Extensive disease of cholangiocarcinoma (CC) determines the overall outcome and limits curative resection. Despite chemotherapy, which has been introduced to improve the outcome of biliary tract malignancies, the benefit in survival is still marginal. CASE PRESENTATION: We report a 69-ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprinzl, Martin F, Schimanski, Carl C, Moehler, Markus, Schadmand-Fischer, Simin, Galle, Peter R, Kanzler, Stephan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564184/
https://www.ncbi.nlm.nih.gov/pubmed/16846514
http://dx.doi.org/10.1186/1471-2407-6-190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564184/
https://www.ncbi.nlm.nih.gov/pubmed/16846514
http://dx.doi.org/10.1186/1471-2407-6-190

Ejemplares similares